Growth Metrics

Nexalin Technology (NXL) Cost of Revenue (2021 - 2025)

Nexalin Technology (NXL) has 5 years of Cost of Revenue data on record, last reported at $3948.0 in Q3 2025.

  • For Q3 2025, Cost of Revenue fell 68.9% year-over-year to $3948.0; the TTM value through Sep 2025 reached $47840.0, up 39.36%, while the annual FY2024 figure was $36593.0, 42.45% up from the prior year.
  • Cost of Revenue reached $3948.0 in Q3 2025 per NXL's latest filing, down from $22838.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $187298.0 in Q3 2022 and bottomed at $3948.0 in Q3 2025.
  • Average Cost of Revenue over 5 years is $29696.4, with a median of $9231.0 recorded in 2021.
  • Peak YoY movement for Cost of Revenue: skyrocketed 1912.66% in 2022, then crashed 97.88% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $9306.0 in 2021, then decreased by 26.21% to $6867.0 in 2022, then dropped by 23.82% to $5231.0 in 2023, then soared by 43.3% to $7496.0 in 2024, then crashed by 47.33% to $3948.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $3948.0 in Q3 2025, $22838.0 in Q2 2025, and $13558.0 in Q1 2025.